Allergan wins round in patent fight over Lumigan
January 28, 2013 at 16:48 PM EST
WASHINGTON, Jan 28 (Reuters) - Specialty pharmaceutical company Allergan Inc won a round in a patent fight against two generic drug makers on Monday when an appeals court found a key portion of the patent for its glaucoma drug, Lumigan, was valid.
